IQVIA Holdings (NYSE:IQV) is expanding its AI driven clinical research solutions and signing new commercial collaborations tied to advanced data services. The company has entered a long term ...

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV) today announced the launch of the Patient Centered Endpoints (PCE) solution, an innovative science and ...

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV) today announced that Chiesi Farmaceutici, the international research-focused healthcare Group (Chiesi Group) is ...

The arrangement includes global product mastering, and simplified access to IQVIA’s resources for data-driven decisions.

IQV is set to report fourth-quarter 2025 earnings results on Feb. 5, with revenues expected to rally 7.2% y/y to $4.2B and ...

IQVIA provides a broad range of services to biopharma customers, including outsourced R&D services in support of clinical trials. Recent spending caution and the end of COVID-related revenue have led ...

By Kamal Choudhury and Sahil Pandey Feb 5 (Reuters) - Healthcare data and clinical research provider IQVIA Holdings on Thursday defended its AI strategy against analyst concerns that recent technology ...

The new Iqvia (formerly Quintiles). Randy Berger Photography To continue reading this content, please enable JavaScript in your browser settings and refresh this page ...

IQVIA Holdings Inc. IQV yesterday unveiled a clinical trial technology platform, One Home for Sites. The platform streamlines the process of management of trials by acting as a single sign-on and a ...

Detailed price information for Iqvia Holdings Inc (IQV-N) from The Globe and Mail including charting and trades.